Results of Holter monitoring in patients with angina pectoris treated by combination of trimethazidine with fabomotisol in the area of former armed conflict

Aim. To assess the effectiveness of trimetazidine and fabomotisol adding to standard treatment in patients with stable angina in the area of former armed conflict in point of improving of Holter monitoring parameters.

Material and methods. One hundred and twelve patients with stable angina of the II-III functional classes (FC) living in the area of former armed conflict were randomly divided into two groups. For 6 months 54 patients (control group) received standard treatment (isosorbide dinitrate 40 mg/day, metoprolole tartras 50-100 mg/day, acetylsalicylic acid 100 mg/day, simvastatin 40 mg/day). Fifty eight patients (study group) in addition to a standard treatment, took trimetazidine 70 mg/day and fabomotisol 30 mg/day. Initially and after 6 months they underwent Holter monitoring.

Results. In patients of the control group the number of episodes of silent myocardial ischemia was statistically significantly reduced (p<0,05). The duration of episodes of silent and manifest myocardial ischemia, ST segment depression >1 mm, and the number of patients with supraventricular and ventricular extrasystoles decreased not statistically significant (p>0,05). The number of episodes of manifest myocardial ischemia did not change. In the study group, the number of silent ischemia episodes, the duration of silent and manifest myocardial ischemia significantly decreased. ST segment depression and the frequency of ventricular extrasystoles were also decreased (p<0,05). At the same time, the changes in number of supraventricular extrasystoles was not statistically significant (p>0,05).  

Conclusion. Using a combination of trimetazidine with fabomotisol in comparison with standard treatment in patients with angina reduces the frequency of angina episodes, the duration of myocardial ischemia, ST segment depression, the frequency of supraventricular and ventricular extrasystoles.

1. Belyalov FI. Depression, anxiety and stress in patients with coronary heart disease. Therapeutic archive. 2017;89(8):104-9. (In Russ.) doi:10.17116/terarkh2017898104-109.

2. Posttraumatic stress disorder. International (Russia-Armenia-Belarus-Ukraine) collective monograph edited by Soldatkin V. A.; GBOU VPO RostGMU of Russian Ministry of health. Rostov-on-Don: Publishing house of RostGMU 2015:624 p. (In Russ.) ISBN 978-5-7453-0511-5.

3. VNOK. Diagnosis and treatment of stable angina. Russian recommendations (2nd revision). Cardiovascular Therapy and Prevention. 2008;7(6). Attachment 4. (In Russ.)

4. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC Guidelines on the management of stable coronary artery disease: the Task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003. doi:10.1093/eurheartj/eht296.

5. Oganov RG, Maslennikova GYa. Features of drug therapy of angina pectoris in men. Cardiovascular Therapy and Prevention. 2014;13(2):61-4. (In Russ.) doi:10.15829/1728-8800-2014-2-61-4.

6. Russian national recommendations on the application of the Holter monitoring method in clinical practice. Russ J Cardiol. 2014;(2):6-71. (In Russ.) doi:10.15829/1560-4071-2014-2-6-71.

7. Islamova UA, Gafurova RM, Abdullaev AA, et al. Holter ECG monitoring and treatment effectiveness control in patients after myocardial infarction. Russ J Cardiol. 2010;6:23-7. (In Russ.) doi:10.15829/1560-40712010-6-23-7.

8. Danchin N, Marzilli M, Parkhomenko A, et al. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology. 2011;120(2): 59-72. doi:10.1159/000332369.

9. Zhidkikh BD. The effectiveness of Afobazole in the treatment of cardiac patients. Vrach. 2014;8:32-7. (in Russ

10. Wei J, Rooks C, Ramadan R, et al. Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease. Am J Cardiol. 2014;114:187-92. doi:10.1016/j.amjcard.2014.04.022.

11. Medvedev VE. Therapy of anxiety disorders in patients with cardiovascular diseases (experience with afobazole). Archive of Internal Medicine. 2013;3(11):70-6. (In Russdoi:10.20514/2226-6704-2013-03-70-76.

12. Sizova ZM, Vladimirov SK. Modern possibilities of myocardial citoprotection in the treatment of pacients with ischemic heart desease. Medical advice. 2016;13:38-43. (In Russ.) doi:10.21518/2079-701X-2016-13-38-43.